Completed OBSERVATIONAL NCT01499680

Multimodality Neuromonitoring in XLIF (NV in XLIF®)

Multimodality Neuromonitoring In eXtreme Lateral Interbody Fusion (XLIF®)

Sponsor: NuVasive

Conditions Degeneration of Lumbar Intervertebral Disc

Updated 9 times since 2017 Last updated: Dec 17, 2025 Started: Oct 31, 2011 Primary completion: Dec 31, 2013 Completion: Jun 30, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Degeneration of Lumbar Intervertebral Disc, this trial is completed. The trial is conducted by NuVasive and has accumulated 9 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

9 versions recorded

Jan 2026 — Present [monthly]

Completed
Sep 2025 — Jan 2026 [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed

▶ Show 4 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

NuVasive

Data source: Globus Medical Inc

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Augusta, United States , Bloomington, United States , Columbia, United States , Conway, United States , Decatur, United States , Durango, United States , Durham, United States , Jefferson City, United States , La Jolla, United States , Las Vegas, United States and 9 more locations